Liver diseases in the elderly: An update

被引:43
作者
Floreani, Annarosa [1 ]
机构
[1] Univ Padua, Dept Surg & Gastroenterol Sci, I-35100 Padua, Italy
关键词
liver diseases in elderly; non-alcoholic fatty liver disease; hepatitis C virus infection; alcoholic liver disease; hepatocellular carcinoma; liver transplantation;
D O I
10.1159/000099478
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Although there are no liver diseases specific to advanced age, the clinical course and management of liver diseases in the elderly may differ in several aspects from those of younger adults. During the last decade an explosion of new knowledge in liver disease has provoked increasing enthusiasm among hepatologists. On the other hand, the development of new emerging conditions (e.g. non-alcoholic steatohepatitis) and novel therapeutic approaches has made it increasingly difficult to validate and assimilate information to be applied in clinical practice. Some liver diseases in the elderly need to be revisited, particularly non-alcoholic fatty liver disease, chronic hepatitis C, alcoholic liver disease, and hepatocellular carcinoma. Moreover, some therapeutic approaches, especially antiviral therapy and liver transplantation, should be discussed also in selected groups of elderly patients. Copyright (C) 2007 S. Karger AG, Basel.
引用
收藏
页码:138 / 143
页数:6
相关论文
共 36 条
[1]   Epidemiology of problem drinking among elderly people [J].
Adams, WL ;
Cox, NS .
INTERNATIONAL JOURNAL OF THE ADDICTIONS, 1995, 30 (13-14) :1693-1716
[2]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[3]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[4]   Liver transplantation from old donors into HCV and non-HCV recipients [J].
Baccarani, U ;
Adani, GL ;
Toniutto, P ;
Sainz, M ;
Lorenzin, D ;
Viale, PL ;
Ramacciato, G ;
Risaliti, A ;
Bresadola, F .
TRANSPLANTATION PROCEEDINGS, 2004, 36 (03) :527-528
[5]   Amantadine and interferon in the combined treatment of hepatitis C virus in elderly patients [J].
Bacosi, M ;
Russo, F ;
D'innocenzo, S ;
Santolamazza, M ;
Miglioresi, L ;
Ursitti, A ;
De Angelis, A ;
Patrizi, F ;
Ricci, GL .
HEPATOLOGY RESEARCH, 2002, 22 (03) :231-239
[6]   Prevalence of and risk factors for hepatic steatosis in northern Italy [J].
Bellentani, S ;
Saccoccio, G ;
Masutti, F ;
Crocè, LS ;
Brandi, G ;
Sasso, F ;
Cristanini, G ;
Tiribelli, C .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (02) :112-117
[7]   Natural history of compensated viral cirrhosis:: a prospective study on the incidence and hierarchy of major complications [J].
Benvegnù, L ;
Gios, M ;
Boccato, S ;
Alberti, A .
GUT, 2004, 53 (05) :744-749
[8]   THE USE OF RECOMBINANT INTERFERON ALFA-2B IN ELDERLY PATIENTS WITH ANTI-HCV-POSITIVE CHRONIC ACTIVE HEPATITIS [J].
BRESCI, G ;
DELCORSO, L ;
ROMANELLI, AM ;
GIULIANO, G ;
PENTIMONE, F .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1993, 41 (08) :857-862
[9]  
Chiaramonte M, 1999, CANCER-AM CANCER SOC, V85, P2132, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2132::AID-CNCR6>3.3.CO
[10]  
2-8